Published in J Lipid Res on September 01, 1989
Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest (1995) 2.33
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest (2008) 2.16
Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms. Circulation (2014) 1.83
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab (2011) 1.53
FoxO1 integrates insulin signaling to VLDL production. Cell Cycle (2008) 1.12
The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short- and long-term effects. Biochem J (1992) 1.09
Storage, mobilization and secretion of cytosolic triacylglycerol in hepatocyte cultures. The role of insulin. Biochem J (1990) 1.05
Monitoring of changes in hepatic fatty acid and glycerolipid metabolism during the starved-to-fed transition in vivo. Studies on awake, unrestrained rats. Biochem J (1993) 1.02
Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem J (1996) 0.98
Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. Proc Natl Acad Sci U S A (1994) 0.92
Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids. Diabetes (2009) 0.91
The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab (2013) 0.85
Acute suppression of apo B secretion by insulin occurs independently of MTP. Biochem Biophys Res Commun (2011) 0.84
Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling. Arterioscler Thromb Vasc Biol (2011) 0.84
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor. J Lipid Res (2008) 0.82
Intracellular degradation in the regulation of secretion of apolipoprotein B-100 by rabbit hepatocytes. Biochem J (1996) 0.81
Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA. Biochem J (1991) 0.81
Post-transcriptional regulation of apolipoprotein E expression in mouse macrophages by phorbol ester. Biochem J (1993) 0.78
Expression of the human apolipoprotein E gene suppresses steroidogenesis in mouse Y1 adrenal cells. Proc Natl Acad Sci U S A (1991) 0.78
Triglycerides and disease. Postgrad Med J (1993) 0.75
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
The continuing challenges of leprosy. Clin Microbiol Rev (2006) 4.09
Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57
Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth (2000) 3.46
Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem (2000) 2.89
Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res (1999) 2.61
PCR identification of Mycobacterium bovis BCG. J Clin Microbiol (1997) 2.60
Postoperative analgesia and respiratory events in patients with symptoms of obstructive sleep apnoea. Anaesth Intensive Care (2009) 2.59
Effect of Desferrioxamine and D.T.P.A. in Iron Overload. Br Med J (1962) 2.47
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
Cytogenetic features of human neuroblastomas and cell lines. Cancer Res (1981) 2.21
Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J Clin Invest (1996) 2.10
Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J Clin Microbiol (1995) 2.08
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation (1993) 2.04
Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2000) 2.00
New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell (1984) 1.99
Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J Infect Dis (1995) 1.98
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89
NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol Sci (1995) 1.88
Delay in the diagnosis of pediatric brain tumors. Am J Dis Child (1986) 1.83
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79
Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa. J Clin Microbiol (1999) 1.74
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta (1972) 1.73
High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem (2000) 1.71
Locus of the alpha-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias. Science (1985) 1.71
Imaging and treatment of B-cell lymphoma. J Nucl Med (1990) 1.68
Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67
Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother (1996) 1.65
Myocardial imaging with thallium-201 at rest and during exercise. Comparison with coronary arteriography and resting and stress electrocardiography. Circulation (1977) 1.63
Degradation of apolipoprotein II mRNA occurs via endonucleolytic cleavage at 5'-AAU-3'/5'-UAA-3' elements in single-stranded loop domains of the 3'-noncoding region. J Biol Chem (1989) 1.61
Identification of receptors for neuromedin U and its role in feeding. Nature (2000) 1.60
Randomised comparison of the Classic Laryngeal Mask Airway with the Cobra Perilaryngeal Airway during anaesthesia in spontaneously breathing adult patients. Anaesth Intensive Care (2009) 1.54
Apolipoprotein E synthesis in human kidney, adrenal gland, and liver. Proc Natl Acad Sci U S A (1983) 1.51
Secondary structure analysis of apolipoprotein II mRNA using enzymatic probes and reverse transcriptase. Evaluation of primer extension for high resolution structure mapping of mRNA. J Biol Chem (1985) 1.51
Quantitation of transient gene expression after electroporation. Nucleic Acids Res (1992) 1.48
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. J Immunol (1996) 1.45
Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem (1997) 1.44
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
Degradative effect of phenol on endotoxin and lipopolysaccharide preparations from Serratia marcescens. J Bacteriol (1974) 1.39
Discordant occurrence of primary biliary cirrhosis in monozygotic twins. N Engl J Med (1994) 1.39
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J Biol Chem (1996) 1.35
Thermal transitions in mixtures of polydeoxyribodinucleotides. Biopolymers (1970) 1.35
Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc Natl Acad Sci U S A (1997) 1.34
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Apolipoprotein E synthesis in peripheral tissues of nonhuman primates. J Biol Chem (1985) 1.32
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun (1999) 1.32
Effect of a single thymine photodimer on the oligodeoxythymidylate-polydeoxyadenylate interaction. J Am Chem Soc (1971) 1.31
Randomized controlled trial comparing the McGrath videolaryngoscope with the C-MAC videolaryngoscope in intubating adult patients with potential difficult airways. Br J Anaesth (2012) 1.30
Meiotic chromosome alterations produced by progesterone. Nature (1968) 1.30
Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science (1978) 1.29
Apolipoprotein II messenger RNA. Transcriptional and splicing heterogeneity yields six 5'-untranslated leader sequences. J Biol Chem (1984) 1.29
Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates. J Biol Chem (1985) 1.28
Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol (2008) 1.28
Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res (1999) 1.27
Comparison of the effects of tropomyosin and troponin-tropomyosin on the binding of myosin subfragment 1 to actin. Biochemistry (1983) 1.26
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med (1995) 1.25
Gluconeogenesis from propionate in kidney and liver of the vitamin B12-deficient rat. Biochem J (1970) 1.24
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med (2001) 1.22
A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J Biol Chem (1998) 1.22
Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem (2001) 1.20
The radionuclide ejection fraction: a comparison of three radionuclide techniques with contrast angiography. J Nucl Med (1977) 1.18
Analysis of human antibody epitopes on the 65-kilodalton protein of Mycobacterium leprae by using synthetic peptides. Infect Immun (1989) 1.18
A Community-wide epidemic of hepatitis A in Ohio. Am J Epidemiol (1986) 1.18
The influence of glucan polymer structure and solution conformation on binding to (1-->3)-beta-D-glucan receptors in a human monocyte-like cell line. Glycobiology (2000) 1.18
Apoliproproteins and lipoproteins. Atherosclerosis (1971) 1.17
Homologs of Mycobacterium leprae 18-kilodalton and Mycobacterium tuberculosis 19-kilodalton antigens in other mycobacteria. Infect Immun (1993) 1.17
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant (1994) 1.17
Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. Am J Cardiol (1978) 1.16
Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry (2000) 1.16
Comparison of effects of smooth and skeletal muscle tropomyosins on interactions of actin and myosin subfragment 1. Biochemistry (1984) 1.16
Estrogen-induced destabilization of yolk precursor protein mRNAs in avian liver. J Biol Chem (1988) 1.16
Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am J Physiol (1992) 1.15
Measurement of apolipoprotein mRNA by DNA-excess solution hybridization with single-stranded probes. Methods Enzymol (1986) 1.15
Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem (1976) 1.15
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet (1991) 1.15
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation (1994) 1.14
Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer (1979) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood (1982) 1.13
Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett (1973) 1.13
De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13
Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol. J Biol Chem (1989) 1.13
Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry (1970) 1.12
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group. Cephalalgia (1999) 1.12
Breakpoints in the human T-cell antigen receptor alpha-chain locus in two T-cell leukaemia patients with chromosomal translocations. Nature (1985) 1.11
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08. Biochemistry (1973) 1.11
Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2+ sources. Chem Biol (1996) 1.09
Kupffer cell:hepatocyte cocultures release nitric oxide in response to bacterial endotoxin. J Surg Res (1990) 1.09
Protective effect of glucan in experimentally induced candidiasis. J Reticuloendothel Soc (1978) 1.08
Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J Biol Chem (1999) 1.07